TRAP1 and Parkinson disease: In agreement with this assumption, negative modulation of TRAP1 protein levels has been frequently reported in in vitro and in vivo models of Parkinson's disease (PD) (Pridgeon et al., 2007; Costa et al., 2013; Zhang et al., 2013; Fitzgerald et al., 2017).